Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma
| Condition | Intervention |
|---|---|
|
Posttraumatic Stress Disorder |
Behavioral: Lifespan Integration Therapy Behavioral: Lifespan Integration- Control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Lifespan Integration Therapy for Posttraumatic Stress Disorder of Adults Involved in an Auto Accident |
- Clinicians Administered PTSD Scale [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ] [ Designated as safety issue: No ]Participants will be assessed with the CAPS following the final treatment session (up to 5 treatment sessions).
- Personality Assessment Inventory [ Time Frame: following the final treatment session (average of 6 weeks from treatment start date) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 18 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | July 2011 |
| Estimated Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Lifespan Integration Therapy (LI) |
Behavioral: Lifespan Integration Therapy
LI treatment guides the client to imaginally visit past memories, and then leads her or him forward through time to the present using a concept referred to as the time line. Beginning with the individual's memories from the traumatic experience, the time line first follows memories from the days and weeks after the trauma, then season by season to the present, and is reviewed in ongoing sessions as increasing details of the traumatic event are uncovered.
|
| Active Comparator: Waitlist Control- Lifespan Integration |
Behavioral: Lifespan Integration- Control
Participants selected for the control group will be treated 4 weeks following initial contact. Treatment is the same as for the Experimental Group.
|
Detailed Description:
Studies estimate a substantial proportion of MVA survivors, ranging from 9.4% to 59.9%, will develop PTSD following an accident (Blanchard & Hickling, 2004). Based on conservative estimates, past research, indicates that MVA-related PTSD may affect 2.5 to 7 million persons in the United States (Blanchard & Hickling). Furthermore, two seminal epidemiological studies (Kessler et al., 1995; Norris, 1992) that focused on causes of adult PTSD identified MVAs as the most frequent trauma resulting in PTSD. For these reasons, MVA-resultant PTSD represents a significant public health problem that needs not only to be thoroughly understood, but addressed with successful mental health treatment options (Beck & Coffey, 2007; Blanchard & Hickling, 1997, 2004; Bryant et al., 1998; Taylor et al., 1999; Taylor et al., 2001). Although there is empirical literature on the treatment of PTSD following an MVA, additional efficacious and rigorously conducted studies with statistical underpinnings are required to determine the results that can be expected from alternative models of care (Beck & Coffey; Blanchard & Hickling, 1997, 2004).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Involved in or witnessed a car accident at least 6 months ago.
- PTSD or distress or impairment in important areas of functioning following the car accident
Exclusion Criteria:
- moderate or severe head injury
- current mental health treatment for the MVA-related problem
- severe chronic pre-injury mental health problems
Contacts and Locations| Contact: Elana Rosencrantz, MA | 425-954-3227 | info@elanarosencrantz.com |
| United States, Washington | |
| Argosy University Seattle | Recruiting |
| Seattle, Washington, United States, 98103 | |
| Principal Investigator: Elana Rosencrantz, MA | |
| Study Chair: | Frances Parks, PhD | Argosy University Seattle |
More Information
Additional Information:
No publications provided
| Responsible Party: | Elana Rosencrantz, Argosy University Seattle |
| ClinicalTrials.gov Identifier: | NCT01263067 History of Changes |
| Other Study ID Numbers: | 2010-10 |
| Study First Received: | December 15, 2010 |
| Last Updated: | December 17, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Argosy University:
|
Posttraumatic Stress Disorder PTSD Car Accident Auto Accident Lifespan Integration |
Additional relevant MeSH terms:
|
Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Anxiety Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 17, 2013